Restoring Serotonergic Homeostasis in the Lateral Hypothalamus Rescues Sleep Disturbances Induced by Early-Life Obesity
Autor: | Mayumi Kimura, Anna Pissioti, Mary Gazea, Alexandre V. Patchev, Este Leidmaa, Elmira Anderzhanova, Osborne F. X. Almeida, Cornelia Flachskamm |
---|---|
Rok vydání: | 2017 |
Předmět: |
0301 basic medicine
Male Sleep Wake Disorders medicine.medical_specialty Serotonin Lateral hypothalamus Serotonergic 03 medical and health sciences Mice 0302 clinical medicine Neurochemical Internal medicine Medicine Animals Homeostasis Peptide YY Obesity Research Articles business.industry General Neuroscience Neuropeptide Y receptor Sleep in non-human animals Peptide Fragments Orexin Mice Inbred C57BL 030104 developmental biology Endocrinology Hypothalamic Area Lateral Wakefulness business 030217 neurology & neurosurgery |
Zdroj: | The Journal of neuroscience : the official journal of the Society for Neuroscience. 38(2) |
ISSN: | 1529-2401 |
Popis: | Early-life obesity predisposes to obesity in adulthood, a condition with broad medical implications including sleep disorders, which can exacerbate metabolic disturbances and disrupt cognitive and affective behaviors. In this study, we examined the long-term impact of transient peripubertal diet-induced obesity (ppDIO, induced between 4 and 10 weeks of age) on sleep–wake behavior in male mice. EEG and EMG recordings revealed that ppDIO increases sleep during the active phase but reduces resting-phase sleep quality. This impaired sleep phenotype persisted for up to 1 year, although animals were returned to a non-obesiogenic diet from postnatal week 11 onwards. To better understand the mechanisms responsible for the ppDIO-induced alterations in sleep, we focused on the lateral hypothalamus (LH). Mice exposed to ppDIO did not show altered mRNA expression levels of orexin and melanin-concentrating hormone, two peptides that are important for sleep–wake behavior and food intake. Conversely, the LH of ppDIO-exposed mice had reduced contents of serotonin (5-hydroxytryptamine, 5-HT), a neurotransmitter involved in both sleep–wake and satiety regulation. Interestingly, an acute peripheral injection of the satiety-signaling peptide YY 3–36 increased 5-HT turnover in the LH and ameliorated the ppDIO-induced sleep disturbances, suggesting the therapeutic potential of this peptide. These findings provide new insights into how sleep–wake behavior is programmed during early life and how peripheral and central signals are integrated to coordinate sleep.SIGNIFICANCE STATEMENTAdult physiology and behavior are strongly influenced by dynamic reorganization of the brain during puberty. The present work shows that obesity during puberty leads to persistently dysregulated patterns of sleep and wakefulness by blunting serotonergic signaling in the lateral hypothalamus. It also shows that pharmacological mimicry of satiety with peptide YY3–36can reverse this neurochemical imbalance and acutely restore sleep composition. These findings add insight into how innate behaviors such as feeding and sleep are integrated and suggest a novel mechanism through which diet-induced obesity during puberty imposes its long-lasting effects on sleep–wake behavior. |
Databáze: | OpenAIRE |
Externí odkaz: |